Results 91 to 100 of about 85,964 (197)

Monoclonal light chain crystalline podocytopathy and tubulopathy associated with monoclonal gammopathy of renal significance: a case report and literature review

BMC Nephrology, 2018
Background Monoclonal gammopathy of renal significance (MGRS) is a recently defined group of renal diseases caused by monoclonal immunoglobulin secreted by nonmalignant proliferative B cell or plasma cell.
Xiao-juan Yu, Xu-jie Zhou, Su-xia Wang, Fu-de Zhou, Ming-hui Zhao   +4 more
doaj   +1 more source

A minor high‐grade component in non‐invasive papillary urothelial carcinoma is not associated with a more indolent behaviour

Histopathology, Volume 88, Issue 7, Page 1430-1442, June 2026.
Non‐invasive papillary urothelial carcinomas with minor high‐grade component are not associated with a more indolent behavior and should likely be regarded as high‐grade carcinomas. Aims The latest WHO edition proposed using a cut‐off of ≥5% high‐grade component (%HGc) as a criterion to label non‐invasive papillary urothelial carcinomas as high‐grade ...
Mina S. Farag, Neda Oghbaei, Jaffar Hussain, André Lametti, Wassim Kassouf, Fadi Brimo   +5 more
wiley   +1 more source

Increased burden on metropolitan urological services: The era of the Australian National Emergency Access Targets (NEAT or the “4-h target”)

Urology Annals, 2018
Background: The National Emergency Access Targets (NEAT) was introduced in Australia in 2011 and guides the clearance of presentations within 4-h of initial presentation from the Emergency Department (ED).
Marlon L Perera, Neiraja Gnaneswaran, Matthew J Roberts, Nathan Lawrentschuk, Peter Ritchie, Steven TF Chan   +5 more
doaj   +1 more source

Molecular subtype concordance and metastatic patterns in muscle‐invasive bladder cancer

The Journal of Pathology: Clinical Research, Volume 12, Issue 3, May 2026.
Abstract Molecular subtypes are potential prognostic and predictive tools in muscle‐invasive bladder cancer (MIBC). However, subtype concordance between primary tumors and metastases, as well as subtype‐specific differences in metastatic patterns, remain poorly characterized.
Csilla Olah, Dániel Juhász, Melinda Váradi, Henning Reis, Mulham Al‐Nader, Osama Mahmoud, Barbara T. Grünwald, Viktor Grünwald, Boris Hadaschik, Péter Nyirády, Tibor Szarvas   +10 more
wiley   +1 more source

Saudi oncology society and Saudi urology association combined clinical management guidelines for renal cell carcinoma 2017

Urology Annals, 2018
In this report, we update the previously published Saudi guidelines for the evaluation and medical and surgical management of renal cell carcinoma. It is categorized according to the stage of the disease using the tumor node metastasis staging system 7th
Abdullah Alsharm, Shouki Bazarbashi, Abdullah Alghamdi, Sultan Alkhateeb, Ali Aljubran, Ashraf Abusamra, Hulayel Alharbi, Mohammed Alotaibi, Mubarak Almansour, Hussein Alkushi, Imran Ahmed, Esam Murshid, Amin Eltijani, Danny Rabah   +13 more
doaj   +1 more source

Bladder Cancer Incidence Trends in the United States From 2000 to 2020

Cancer Reports, Volume 9, Issue 5, May 2026.
ABSTRACT Background Bladder cancer is one of the most common urogenital cancers globally. Here, we aimed to report the incidence trend of bladder cancer in the United States (US) over 2000–2020, by age, sex, race/ethnicity, and types using Surveillance, Epidemiology, and End Results (SEER). Methods We used SEER 22 data to calculate the age‐standardized
Seyed Ehsan Mousavi, Ryan Michael Antar, Armin Aslani, Pourya Shokri, Zahra Yekta, Amin Bateni, Nasser Shakhssalim, Seyed Aria Nejadghaderi   +7 more
wiley   +1 more source

Influence of statin use on clinicopathological characteristics of localized prostate cancer and outcomes obtained after radical prostatectomy: a single center study [PDF]

, 2015
To assess the impact of statin use on biochemical recurrence (BCR) of prostate cancer after radical prostatectomy (RP)
Cattarino, Susanna, Comperat, Eva, Cussenot, Olivier, Drouin, Sarah J, Leon, Priscilla, Mozer, Pierre, Renard Penna, Raphaële, Rouprêt, Morgan, Seisen, Thomas   +8 more
core  

Real‐world efficacy and toxicity of ipilimumab and nivolumab as a first‐line treatment for advanced renal cell carcinoma according to IMDC risk criteria—A multi‐center retrospective analysis on behalf of the GUARDIANS group

International Journal of Cancer, Volume 158, Issue 9, Page 2440-2451, 1 May 2026.
What's new? The combination of ipilimumab and nivolumab as a first‐line treatment for advanced renal cell carcinoma has demonstrated durable response and tolerability in clinical trials. However, inclusion criteria for clinical studies are restrictive, and patients in the real‐world setting tend to have more comorbidities.
Hendrik Dinkel, Linus Materna, Ramona Stelmach, Stefanie Zschäbitz, Stephanie Neuberger, Can D. Aydogdu, Jozefina Casuscelli, Timo Egenolf, Matteo Silberg, Julie Steinestel, Arne Strauss, Florian Kirchhoff, Marit Ahrens, Pia Paffenholz, Richard Cathomas, Berna C. Özdemir, Christopher Gossler, Philipp Ivanyi, Marc Rehlinghaus, Thomas Hilser, Viktor Grünwald, Katrin Schlack   +21 more
wiley   +1 more source

A Case of Testicular Malakoplakia With Markedly High Signal Intensity on Fat‐Suppressed T1‐Weighted Images

IJU Case Reports, Volume 9, Issue 3, May 2026.
ABSTRACT Introduction Testicular malakoplakia is a very rare, chronic granulomatous inflammatory condition that frequently resembles testicular malignancy on imaging studies. Here, we report a case of testicular malakoplakia with characteristic magnetic resonance imaging (MRI) findings and present a brief review of the literature.
Fumiko Yagi, Hirotaka Akita, Takeo Kosaka, Akihisa Ueno, Teppei Kotera, Masato Kobayashi, Hideaki Mekada, Mototsugu Oya, Masahiro Jinzaki   +8 more
wiley   +1 more source

Intratumoral Microorganisms in Tumors: Current Understanding and Emerging Therapeutic Strategies

MedComm, Volume 7, Issue 5, May 2026.
Tumors are no longer viewed as sterile but dynamic ecosystems harboring low‐biomass intratumoral microbiota. These microbes, derived from gut, oral cavity, or circulation, shape tumorigenesis and therapy response via core mechanisms: immunomodulation (regulating T cells, macrophages), metabolic reprogramming (SCFAs, indoles, bile acids), chronic ...
Haoling Zhang, Zengkan Du, Ping Lu, Aimin Jiang, Yadong Guo, Yawei Liu, Zhijing Song, Bing Dai, Wangzheqi Zhang   +8 more
wiley   +1 more source